EWTX
Edgewise Therapeutics, Inc. · Healthcare
Chief Business Officer Behrad Derakhshan sold $32K of Edgewise Therapeutics, Inc.
Sold$32,487
$18.91Price
1,718Shares
−11%Stake
What EWTX did after the filing
- The stock from Fri, May 3 close, $19.52
- −11.0%
- S&P 500, same days
- +7.0%
Measured over 30 trading days, to the Jun 17 close.
Traded Thu, May 2. Filed Fri, May 3, 2:29 PM ET, during the session. Returns use the May 3 close and the Jun 17 close. Not investment advice.